High Rate of Recurrent De Novo Mutations in Developmental and Epileptic EncephalopathiesFadi F. Hamdan, Monica H. Wojcik, Sylvia Dobrzeniecka et al.|The American Journal of Human Genetics|2017Cited by 456
Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesisMichèl A.A.P. Willemsen, Ron A. Wevers, Marcel M. Verbeek et al.|Brain|2010Cited by 233
<i><scp>RYR</scp>1</i>‐related myopathies: a wide spectrum of phenotypes throughout lifeMarc Snoeck, Erik‐Jan Kamsteeg|European Journal of Neurology|2015Cited by 143
Congenital myopathy caused by a novel missense mutation in the CFL2 geneCharlotte W. Ockeloen, Nens van Alfen, H. Jacobus Gilhuis et al.|Neuromuscular Disorders|2012Cited by 60
Biallelic loss of function variants in <scp><i>SYT2</i></scp> cause a treatable congenital onset presynaptic myasthenic syndromeSandra Donkervoort, Carsten G. Bönnemann, Payam Mohassel et al.|American Journal of Medical Genetics Part A|2020Cited by 29